AVE8062
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for AVE8062, covering 2011-06-13 to 2015-12-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies [Phase 3]